Table 1. Patient demographics.
| Patient characteristics before treatment | Cryoablation (n = 26) | Cryo-NK (n = 35) | P value |
|---|---|---|---|
| Gender (Male/Female) | 14/12 | 18/17 | P = 0.824 |
| Median age (y) | 56 | 61 | P = 0.715 |
| Child-Pugh Stratification | P = 0.763 | ||
| Class A | 11 | 16 | |
| Class B | 15 | 19 | |
| Clinical stage (AJCC) | P = 0.864 | ||
| III | 12 | 17 | |
| IV | 14 | 18 | |
| Karnofsky performance status | P = 0.744 | ||
| 70 | 13 | 14 | |
| 80 | 8 | 15 | |
| 90 | 5 | 6 | |
| Hepatitis B/C+ | 12 | 14 | P = 0.836 |
| TACE | 23 | 22 | P = 0.922 |
AJCC, American Joint Committee on Cancer staging system; TACE, Transarterial chemoembolization.